Artelo Biosciences (ARTL) Times Interest Earned (2014 - 2025)
Artelo Biosciences (ARTL) posted quarterly Times Interest Earned of $107.15 for Q4 2025, up 16060.64% year-over-year from N/an in Q4 2024, and up 485.05% quarter-over-quarter from -$27.83 in Q3 2025.
Artelo Biosciences (ARTL) Times Interest Earned (2014 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Times Interest Earned for 10 consecutive years, with $107.15 the latest figure, recorded in Q4 2025.
- In Q4 2025, Times Interest Earned rose 16060.64% year-over-year to $107.15; the TTM figure through Dec 2025 stood at -$122.62 (down 6788.18% YoY), while the FY2025 annual figure was -$1.46, up 18.05% from the prior year.
- Times Interest Earned climbed to $107.15 in Q4 2025 per ARTL's latest filing, from -$27.83 in the prior quarter.
- Across five years, Times Interest Earned topped out at $695.2 in Q4 2022 and bottomed at -$478.8 in Q3 2022.
- Historically, Times Interest Earned has averaged -$58.68 across 5 years, with a median of -$81.08 in 2022.
- Annual changes were most pronounced in 2023 — Times Interest Earned tumbled 156.97% — and 2025, when it soared 16060.64%.
- Artelo Biosciences' Times Interest Earned stood at -$29.48 in 2021, then surged by 2458.49% to $695.2 in 2022, then tumbled by 111.75% to -$81.69 in 2023, then soared by 99.18% to -$0.67 in 2024, then jumped by 16060.64% to $107.15 in 2025.
- Business Quant data shows ARTL's Times Interest Earned at $107.15 in Q4 2025, -$27.83 in Q3 2025, and -$5.99 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Artelo Biosciences | 107,735.40 | -492,264.60 | - | -253.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 107.15 |
| Sep 30, 2025 | -27.83 |
| Jun 30, 2025 | -5.99 |
| Mar 31, 2025 | -264.33 |
| Dec 31, 2024 | -0.67 |
| Sep 30, 2024 | -149.38 |
| Jun 30, 2024 | -125.60 |
| Mar 31, 2024 | -152.29 |
| Sep 30, 2023 | -81.69 |
| Jun 30, 2023 | -74.33 |
| Mar 31, 2023 | -208.36 |
| Dec 31, 2022 | 695.20 |
| Sep 30, 2022 | -478.80 |
| Jun 30, 2022 | -107.43 |
| Mar 31, 2022 | -81.08 |
| May 31, 2021 | -29.48 |
| Feb 28, 2021 | -12.59 |
| Nov 30, 2019 | -16.44 |
| Aug 31, 2017 | -55.02 |
| May 31, 2017 | -105.54 |